US Venture Partners X LP's Form 4 filing
eFFECTOR Therapeutics, Inc. (EFTR) · filed Dec 1, 2021
- Accession no.
- 0001062993-21-011920
- Filed
- Dec 1, 2021, 6:31 PM ET
- Trade date
- Nov 29-Dec 1, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $475.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| US Venture Partners X LPCIK 0001440514 | 10% Owner |
| Usvp X Affiliates LPCIK 0001453359 | 10% Owner |
| Tansey Casey MCIK 0001474322 | 10% Owner |
| Presidio Management Group X LLCCIK 0001602744 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 29, 2021 | Common Stock | SSaleDisposed | −24,965 | $6.70 | −$167,140.68 | 4,437,369 | Indirect | |
| Nov 29, 2021 | Common Stock | SSaleDisposed | −799 | $6.70 | −$5,349.31 | 141,960 | Indirect | |
| Nov 30, 2021 | Common Stock | SSaleDisposed | −26,559 | $6.53 | −$173,483.39 | 4,410,810 | Indirect | |
| Nov 30, 2021 | Common Stock | SSaleDisposed | −850 | $6.53 | −$5,553.05 | 141,110 | Indirect | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −18,648 | $6.44 | −$120,037.18 | 4,392,162 | Indirect | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −597 | $6.44 | −$3,842.89 | 140,513 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.